MYRIAD GENETICS, INC. Debt Instrument, Interest Rate, Effective Percentage
MYRIAD GENETICS, INC. (MYGN) had Debt Instrument, Interest Rate, Effective Percentage of 6.00% as of 2013-06-30, per its 10-K filed 2013-08-14.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateEffectivePercentage · last filed 2013-08-14
- 2013-06-30: Debt Instrument, Interest Rate, Effective Percentage 6.00%.
- 2012-09-30: Debt Instrument, Interest Rate, Effective Percentage 7.00%.
- 2012-06-30: Debt Instrument, Interest Rate, Effective Percentage 6.00%.
- 2012-03-31: Debt Instrument, Interest Rate, Effective Percentage 6.00%.
| Period end | Debt Instrument, Interest Rate, Effective Percentage |
|---|---|
| 2013-06-30 | 6.00% 10-K · filed 2013-08-14 |
| 2012-09-30 | 7.00% 10-K · filed 2013-08-14 |
| 2012-06-30 | 6.00% 10-K · filed 2012-08-15 |
| 2012-03-31 | 6.00% 10-Q · filed 2012-05-02 |
| 2011-12-31 | 6.00% 10-Q · filed 2012-02-01 |
| 2011-09-30 | 6.00% 10-Q · filed 2013-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |